Antioxidant effects of alpha lipoic acid on dialytic patients
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease.Chronic kidney disease, stage 5 on dialysis
- Registration Number
- IRCT2013051813360N1
- Lead Sponsor
- Tabriz university of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion: 1-acceptance and compliance of patients 2- history of 6 months hemodialysis or more 3- 3 session of hemodialysis every week
Exclusion:1- hepatitis B and any active infection 2-Age<20 3-non steroid anti-inflammatory drugs, steroid,Vitamin-C, Vit E, Valproat Na use 4- Smoking 5- Advers reaction and sensitivity to alpha lipoic acid 6- Gastrointestinal disorders 7- pregnancy and breast feeding 8- candidates for recent kidney trancplantation (less than 1 month )
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interleukin-8. Timepoint: Time zero and 60 days after intervention. Method of measurement: ELISA kit.;TNF-alpha. Timepoint: Time zero and 60 days after intervention. Method of measurement: ELISA kit.
- Secondary Outcome Measures
Name Time Method